+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Intelligence in Diabetes Management Market - Global Forecast 2026-2032- Product Image
Artificial Intelligence in Diabetes Management Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Intelligence in Diabetes Management Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904643
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Intelligence in Diabetes Management Market is projected to reach USD 1.72 Billion in 2026. It is expected to continue growing at a CAGR of 31.66%, reaching USD 9.04 Billion by 2032.

Artificial intelligence in diabetes management is moving from pilot projects to operational care infrastructure as health systems confront rising prevalence, clinician shortages, and the need for continuous, personalized support. The International Diabetes Federation estimated that 537 million adults lived with diabetes in 2021, with the total projected to reach 643 million by 2030 and 783 million by 2045, creating sustained demand for AI-enabled glucose monitoring, predictive analytics, insulin titration support, and remote patient management.

For providers and payers, the strongest value proposition is measurable improvement in risk stratification, adherence, early intervention, and workflow efficiency. AI tools that integrate electronic health records, continuous glucose monitoring data, claims, laboratory results, and behavioral signals can support earlier detection of hypoglycemia risk, diabetes complications, and care gaps while improving population health management.

Transformative Shifts Reshaping Diabetes Care

The landscape is being reshaped by connected devices, cloud-based analytics, regulatory modernization, and wider adoption of continuous glucose monitoring. The American Diabetes Association’s Standards of Care increasingly recognize the role of diabetes technology, including continuous glucose monitoring and automated insulin delivery, while regulators are refining expectations for software as a medical device, clinical decision support, cybersecurity, and adaptive algorithms.

A major shift is the transition from episodic clinic-based diabetes care to continuous, data-driven care. AI-powered decision support can identify patients who need medication review, nutrition coaching, retinal screening, nephropathy testing, cardiovascular risk assessment, or behavioral support, enabling organizations to move from reactive treatment to proactive chronic disease management.

Cumulative Impact of Artificial Intelligence

The cumulative impact of artificial intelligence is strongest when algorithms are embedded across the full diabetes journey: screening, diagnosis support, therapy optimization, complication detection, adherence management, and outcomes monitoring. Evidence-backed use cases include diabetic retinopathy screening, predictive hypoglycemia alerts, insulin dosing assistance, automated triage of high-risk patients, and risk prediction for kidney, cardiovascular, and foot complications.

At scale, AI can support reductions in avoidable emergency visits, improve time-in-range for insulin users, and strengthen value-based care programs by identifying actionable risk earlier. However, impact depends on validated datasets, transparent performance monitoring, cybersecurity, clinician oversight, regulatory compliance, and equitable access for underserved populations that carry a disproportionate diabetes burden.

Key Regional Insights

Asia-Pacific is central to AI in diabetes management because China and India account for very large diabetes populations, while Japan, Australia, and South Korea have mature digital health ecosystems, connected device adoption, and advanced clinical infrastructure. Across the region, rising type 2 diabetes prevalence, urbanization, smartphone penetration, and government interest in digital health are supporting the use of AI-enabled glucose analytics, remote patient monitoring, and complication screening.

North America remains a leading commercialization environment through advanced reimbursement structures, high continuous glucose monitoring adoption, strong clinical research networks, telehealth normalization, and regulatory pathways for software-enabled diabetes technologies. Europe benefits from national diabetes programs, interoperable health data initiatives, the European Health Data Space agenda, and the EU AI Act’s risk-based governance approach, creating strong demand for trustworthy, clinically validated, and privacy-compliant AI solutions.

Latin America is expanding remote monitoring through private provider networks, public health digitization, and growing attention to chronic disease management in countries with rising obesity and diabetes burdens. The Middle East is prioritizing diabetes prevention and digital care in national health strategies, particularly across Gulf economies where type 2 diabetes prevalence is a major public health concern. Africa remains underpenetrated but offers long-term opportunity through mobile-first screening, community health programs, low-cost AI triage, and diabetic retinopathy detection models suited to resource-constrained settings.

Key Group Insights

ASEAN markets are progressing through mobile health platforms, urban diabetes clinics, expanding insurance coverage, and public-private digital health collaborations, although reimbursement maturity and specialist access vary widely across member states. GCC countries are investing heavily in AI-enabled healthcare as part of national transformation plans, with diabetes management a priority because of high obesity rates, sedentary lifestyle risk factors, and the growing burden of type 2 diabetes.

The European Union is emphasizing trustworthy AI, interoperability, privacy protection, clinical evidence, and post-market monitoring, making compliance a core requirement for AI diabetes management solutions. BRICS countries combine large patient populations with expanding digital infrastructure, creating scale opportunities for AI-enabled screening, remote monitoring, and population health management, while also requiring localized datasets, affordability, and integration with public health systems.

G7 markets provide strong evidence-generation, regulatory clarity, clinical adoption, and reimbursement pathways for AI in diabetes care, particularly where continuous glucose monitoring, electronic health records, and digital therapeutics are already embedded in care models. NATO countries increasingly view health data security, cyber resilience, and supply-chain assurance as strategic requirements, which raises expectations for secure AI deployment, protected patient data exchange, and resilient connected diabetes technologies.

Key Country Insights

The United States is a major innovation and reimbursement market, supported by CDC-reported diabetes prevalence of 38.4 million people and strong adoption of continuous glucose monitoring, telehealth, remote patient monitoring, and regulator-cleared software tools. Canada emphasizes equitable chronic care access, public health coordination, and virtual care adoption, while Mexico is expanding diabetes management through public programs and private provider networks amid a high national burden of type 2 diabetes.

Brazil is advancing digital health and diabetes care through a combination of public health initiatives, private healthcare networks, and growing use of telemedicine. The United Kingdom is strengthening digital diabetes prevention, remote monitoring, and technology-enabled care within a national health system model, while Germany benefits from structured disease management programs, digital health reimbursement mechanisms, and strong medical technology adoption. France is advancing remote monitoring reimbursement and chronic care digitization, Italy and Spain are using regional health systems to expand diabetes technology access, and Russia remains influenced by healthcare localization, procurement requirements, and infrastructure differences across regions.

China offers major scale for AI in diabetes management through large patient volumes, hospital digitization, and rapid adoption of mobile health tools, while India’s opportunity is driven by one of the world’s largest diabetes populations, expanding smartphone use, and growing demand for low-cost screening and coaching. Japan combines aging-population needs with advanced device integration and clinical infrastructure, Australia supports evidence-led digital health adoption through national digital health capabilities, and South Korea leads in connected health infrastructure, broadband penetration, and technology-enabled chronic disease management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated AI models, measurable outcomes, and workflow integration over standalone digital features. The most defensible strategies combine continuous glucose monitoring data, electronic health record integration, behavioral coaching, medication intelligence, insulin dosing support, and complication screening into interoperable diabetes management platforms.

Organizations should invest in regulatory readiness, real-world evidence, cybersecurity, bias testing, model monitoring, and explainable AI. Commercial teams should align product claims with payer and provider priorities such as fewer acute events, improved HbA1c control, better time-in-range, higher screening adherence, and lower total cost of care. Partnerships with providers, pharmacies, employers, public health agencies, and device manufacturers can accelerate adoption while improving access and continuity of care.

Research Methodology

This executive summary is informed by secondary research from recognized sources including the International Diabetes Federation, World Health Organization, U.S. CDC, American Diabetes Association, U.S. FDA guidance, European regulatory frameworks, peer-reviewed clinical literature, national digital health strategies, and public health policy documents.

The methodology emphasizes triangulation across epidemiology, regulatory developments, technology adoption, reimbursement signals, clinical evidence, and healthcare digitization. Insights were assessed for relevance to AI in diabetes management, including continuous glucose monitoring analytics, automated insulin delivery support, clinical decision support, diabetic retinopathy screening, remote patient monitoring, predictive risk stratification, and AI-enabled population health management.

Conclusion

Artificial intelligence is becoming a core enabler of next-generation diabetes management as healthcare systems seek earlier intervention, personalized therapy, and scalable chronic disease support. Momentum is reinforced by rising diabetes prevalence, expanding continuous glucose monitoring adoption, maturing digital health infrastructure, stronger regulatory guidance, and growing acceptance of software-enabled medical care.

The strongest performers will be organizations that prove clinical value, protect patient data, meet regulatory expectations, integrate into care workflows, and deliver equitable outcomes across diverse populations. AI will not replace clinicians, but it will increasingly augment diabetes care teams with predictive insights, automation, continuous patient engagement, and more targeted chronic disease interventions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Intelligence in Diabetes Management Market, by Device Type
7.1. Introduction
7.2. Blood Glucose Meter
7.2.1. Non Invasive Bg Meter
7.2.2. Smbg
7.3. Closed Loop System
7.3.1. Fully Closed Loop
7.3.2. Hybrid Closed Loop
7.4. Continuous Glucose Monitor
7.4.1. Intermittently Scanned Cgm
7.4.2. Real Time Cgm
7.5. Insulin Pump
7.5.1. Patch Pump
7.5.2. Tubed Pump
8. Artificial Intelligence in Diabetes Management Market, by Technology
8.1. Introduction
8.2. Decision Support Systems
8.2.1. Alert Generation
8.2.2. Dose Recommendation
8.3. Machine Learning
8.4. Mobile Applications
8.5. Predictive Analytics
8.5.1. Glucose Trend Prediction
8.5.2. Risk Prediction
9. Artificial Intelligence in Diabetes Management Market, by Component
9.1. Introduction
9.2. Hardware
9.2.1. Pumps
9.2.2. Sensors
9.2.3. Wearable Devices
9.3. Software
9.3.1. Algorithms
9.3.2. Data Management
9.3.3. User Interface
10. Artificial Intelligence in Diabetes Management Market, by Deployment Mode
10.1. Introduction
10.2. Cloud Based
10.2.1. Hybrid Cloud
10.2.2. Public Cloud
10.3. On Premise
10.3.1. Edge Computing
10.3.2. Server Based
11. Artificial Intelligence in Diabetes Management Market, by End User
11.1. Introduction
11.2. Clinic
11.2.1. Diabetes Center
11.2.2. General Clinic
11.3. Home Care
11.3.1. Remote Monitoring
11.3.2. Self Monitoring
11.4. Hospital
11.4.1. Inpatient
11.4.2. Outpatient
11.5. Research Institute
11.5.1. Academic
11.5.2. Private
12. Artificial Intelligence in Diabetes Management Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Artificial Intelligence in Diabetes Management Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Artificial Intelligence in Diabetes Management Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Apple Inc.
16.3. Bigfoot Biomedical, Inc.
16.4. Dexcom, Inc.
16.5. Diabeloop SA
16.6. Eyenuk, Inc.
16.7. F. Hoffmann-La Roche Ltd
16.8. Glooko Inc.
16.9. Google LLC by Alphabet Inc.
16.10. Insulet Corporation
16.11. International Business Machines Corporation
16.12. Livongo Health, Inc.
16.13. Medtronic plc
16.14. Omada Health, Inc.
16.15. Tandem Diabetes Care, Inc.
16.16. Teladoc Health, Inc.
16.17. Tidepool Inc.
16.18. Virta Health Corp.
16.19. Wellthy Therapeutics Pvt. Ltd.
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE METER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL NON INVASIVE BG METER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SMBG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SMBG MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SMBG MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CLOSED LOOP SYSTEM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FULLY CLOSED LOOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL HYBRID CLOSED LOOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL INTERMITTENTLY SCANNED CGM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL REAL TIME CGM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL REAL TIME CGM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL REAL TIME CGM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INSULIN PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INSULIN PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INSULIN PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL PATCH PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL PATCH PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PATCH PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL TUBED PUMP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL TUBED PUMP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL TUBED PUMP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ALERT GENERATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL ALERT GENERATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ALERT GENERATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DOSE RECOMMENDATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL MACHINE LEARNING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MACHINE LEARNING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL MOBILE APPLICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL GLUCOSE TREND PREDICTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RISK PREDICTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL RISK PREDICTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL RISK PREDICTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ALGORITHMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ALGORITHMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ALGORITHMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL USER INTERFACE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL USER INTERFACE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL USER INTERFACE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL EDGE COMPUTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL EDGE COMPUTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL EDGE COMPUTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SERVER BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL SERVER BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL SERVER BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL CLINIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CLINIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CLINIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL DIABETES CENTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL DIABETES CENTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL DIABETES CENTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL GENERAL CLINIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL GENERAL CLINIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL GENERAL CLINIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL SELF MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL SELF MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL SELF MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL HOSPITAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL HOSPITAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL HOSPITAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL INPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL INPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL INPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL OUTPATIENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL OUTPATIENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL OUTPATIENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL RESEARCH INSTITUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ACADEMIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ACADEMIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL ACADEMIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 184. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 185. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 186. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 196. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 207. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 209. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 210. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 211. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 212. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 213. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 215. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 216. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 217. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 218. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 219. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 220. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 221. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 222. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 224. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 225. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 226. EUROPE ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 227. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 228. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 231. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 232. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 235. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 236. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 237. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 238. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 247. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 248. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 249. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 250. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 251. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 252. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 253. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 254. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 255. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 256. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 257. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 258. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 259. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 260. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 261. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 262. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 264. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 265. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 266. AFRICA ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 267. GLOBAL ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 268. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 269. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 270. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 271. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 272. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 273. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 274. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 276. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 277. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 278. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 279. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 280. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 281. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 282. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 283. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 285. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 286. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 287. ASEAN ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 288. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 290. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 291. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 292. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 293. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 294. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 296. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY PREDICTIVE ANALYTICS, 2017-2032 (USD MILLION)
TABLE 297. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 298. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HARDWARE, 2017-2032 (USD MILLION)
TABLE 299. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY SOFTWARE, 2017-2032 (USD MILLION)
TABLE 300. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEPLOYMENT MODE, 2017-2032 (USD MILLION)
TABLE 301. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOUD BASED, 2017-2032 (USD MILLION)
TABLE 302. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY ON PREMISE, 2017-2032 (USD MILLION)
TABLE 303. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 304. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLINIC, 2017-2032 (USD MILLION)
TABLE 305. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOME CARE, 2017-2032 (USD MILLION)
TABLE 306. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY HOSPITAL, 2017-2032 (USD MILLION)
TABLE 307. GCC ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTE, 2017-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY BLOOD GLUCOSE METER, 2017-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CLOSED LOOP SYSTEM, 2017-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITOR, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY INSULIN PUMP, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT MARKET SIZE, BY DECISION SUPPORT SYSTEMS, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN DIABETES MANAGEMENT M

Companies Mentioned

  • Abbott Laboratories
  • Apple Inc.
  • Bigfoot Biomedical, Inc.
  • Dexcom, Inc.
  • Diabeloop SA
  • Eyenuk, Inc.
  • F. Hoffmann-La Roche Ltd
  • Glooko Inc.
  • Google LLC by Alphabet Inc.
  • Insulet Corporation
  • International Business Machines Corporation
  • Livongo Health, Inc.
  • Medtronic plc
  • Omada Health, Inc.
  • Tandem Diabetes Care, Inc.
  • Teladoc Health, Inc.
  • Tidepool Inc.
  • Virta Health Corp.
  • Wellthy Therapeutics Pvt. Ltd.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.04 Billion
Compound Annual Growth Rate31.6%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Digital Diabetes Management Market - Global Forecast 2026-2032 - Product Image

Digital Diabetes Management Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2026-2034 - Product Image

Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Artificial Intelligence in Diabetes Management Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Artificial Intelligence in Diabetes Management Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Artificial Intelligence in Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Artificial Intelligence in Diabetes Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Artificial Intelligence in Diabetes Management Market Report 2026 - Product Image

Artificial Intelligence in Diabetes Management Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Artificial Intelligence in Diabetes Management Market

In the field of medical devices, the Artificial Intelligence in Diabetes Management market comprises a range of technologies aimed at assisting patients with diabetes and healthcare professionals to monitor, treat, and manage the disease more effectively. These include, but are not limited to, devices such as smart glucose meters, continuous glucose monitoring systems (CGMs), insulin pumps, and automated insulin delivery systems, all of which have incorporated AI algorithms to improve functionality. The integration of AI helps in predicting glucose levels fluctuations, offering personalized dosage recommendations, and identifying patterns in blood glucose data that may indicate a need for therapeutic adjustments. AI-driven solutions in this market are designed to ease the burden of daily diabetes management tasks, reduce the incidence of hypo- and hyperglycemic events, and overall improve the quality of life for people with diabetes. Advances in machine learning, predictive analytics, and data processing have greatly enhanced the performance of such devices, leading to more autonomous and patient-tailored diabetes care. Prominent companies operating in the Artificial Intelligence in Diabetes Management market include Medtronic, which offers AI-integrated insulin pumps and CGM systems; Dexcom, known for its sophisticated CGMs; Insulet Corporation, creator of the Omnipod insulin management system; and Abbott Laboratories, the company behind the FreeStyle Libre glucose monitoring technology. Other notable players include Tandem Diabetes Care and Diabnext, which have also developed innovative AI-driven medical devices and management platforms for diabetes care. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.